Skip to main content
. 2021 Sep 30;12:728108. doi: 10.3389/fneur.2021.728108

Table 1.

Demographic and clinical characteristics of patients diagnosed with Alzheimer's disease (AD) and behavioral variant frontotemporal dementia (bvFTD).

Characteristics bvFTD (n = 31) AD (n = 28)
Mean SD Mean SD p-value
Women n (%) 13 (41.90%) 17 (60.71%) 0.195a
Age (range: 50–87) 66.94 9.26 74.15 9.22 0.004b
Schooling (0–21 Years) 11.74 4.57 9.43 4.49 0.055b
Clinical characteristics
   MMSE (Baseline) 23.61 4.96 23.35 3.54 0.397b
   MMSE (1 Year) 22.50 4.69 22.87 3.91 0.775b
0.005 c 0.043c
   ACER (Baseline) 71.71 16.36 67.57 11.77 0.173b
   ACER (1 Year) 69.32 15.54 66.61 11.51 0.563b
0.001c 0.028c
   EXIT-25 (Baseline) 14.96 9.36 12.43 7.82 0.353b
   EXIT-25 (1 Year) 16.74 10.28 12.90 9.04 0.256b
0.028c 0.753c
   IFS (Baseline) 15.42 6.35 16.41 5.06 0.973b
   IFS (1 Year) 15.02 6.34 16.06 5.13 0.942b
0.423c 0.108c
   FAB (Baseline) 12.42 4.07 13.75 2.69 0.607b
   FAB (1 Year) 12.35 4.02 13.60 2.74 0.386b
1.00c 1.00c
   NPI Total (Baseline) 45.58 23.85 25.64 16.92 0.001b
   NPI Total (1 Year) 47.90 22.88 28.36 19.46 0.001b
0.008c 0.043c
   NPI Distress (Baseline) 19.16 10.19 12.29 8.20 0.007b
   NPI Distress (1 Year) 20.13 9.76 13.11 8.63 0.006b
0.005c 0.028c
a

Chi-square Test.

b

Mann-Whitney U Test.

c

Wilcoxon Matched Pairs Test.

AD, Alzheimer's disease; bvFTD, behavioral variant frontotemporal dementia; MMSE, Mini Mental State Examination; ACE-R, Addenbrooke's Cognitive Examination-Revised; EXIT-25, Executive Interview with 25 items; IFS, INECO Frontal Screening; FAB, Frontal Assessment Battery.